Literature DB >> 24205872

Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: sensitivity and trim and fill studies.

Jie Liu1, Hong-xin Zhang, Xiong-xiong Lu, Jia-jia Hu, Lian-fu Deng.   

Abstract

OBJECTIVE: This study carried out sensitivity analysis and trim-fill analysis between bisphosphonates and subtrochanteric, femoral shaft, and atypical femur fracture.
METHODS: A random-effects model was used finally. Sensitivity, trim and fill, and publication bias analyses were done.
RESULTS: Under a random-effects model (I(2)=87.535), the Z-value=5.672, p-value of test of null<0.001. Bisphosphonate exposure was associated with an increased risk of atypical femur fracture (3.243 [95% CI 2.160-4.870]). When any study is removed, the remaining sensitivity analysis results are still significant. Trim and fill results show that two studies were missed. After filling them, a funnel plot of precision by log risk ratio was more symmetrical.
CONCLUSION: This study suggests that (1) there is an increased risk of subtrochanteric, femoral shaft, and atypical femur fracture in bisphosphonate users; (2) any single study does not influence the total sensitivity; (3) two studies have been lost, theoretically.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24205872      PMCID: PMC3926151          DOI: 10.1089/gtmb.2013.0331

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  20 in total

1.  Atypical femoral fractures and bisphosphonate use.

Authors:  Christian M Girgis; Doron Sher; Markus J Seibel
Journal:  N Engl J Med       Date:  2010-05-13       Impact factor: 91.245

2.  Incidence and demography of femur fractures with and without atypical features.

Authors:  Adrianne C Feldstein; Dennis Black; Nancy Perrin; A Gabriela Rosales; Darin Friess; David Boardman; Richard Dell; Arthur Santora; Julie M Chandler; Mary M Rix; Eric Orwoll
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

Review 3.  Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis.

Authors:  Lydia Gedmintas; Daniel H Solomon; Seoyoung C Kim
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

4.  Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.

Authors:  Raphael P H Meier; Thomas V Perneger; Richard Stern; René Rizzoli; Robin E Peter
Journal:  Arch Intern Med       Date:  2012-06-25

5.  Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women.

Authors:  Laura Y Park-Wyllie; Muhammad M Mamdani; David N Juurlink; Gillian A Hawker; Nadia Gunraj; Peter C Austin; Daniel B Whelan; Peter J Weiler; Andreas Laupacis
Journal:  JAMA       Date:  2011-02-23       Impact factor: 56.272

6.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

7.  Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene.

Authors:  P Vestergaard; F Schwartz; L Rejnmark; L Mosekilde
Journal:  Osteoporos Int       Date:  2010-12-17       Impact factor: 4.507

8.  Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

Authors:  T Mashiba; T Hirano; C H Turner; M R Forwood; C C Johnston; D B Burr
Journal:  J Bone Miner Res       Date:  2000-04       Impact factor: 6.741

9.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

10.  Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.

Authors:  Seo Young Kim; Sebastian Schneeweiss; Jeffrey N Katz; Raisa Levin; Daniel H Solomon
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

View more
  3 in total

1.  Reduced diaphyseal strength associated with high intracortical vascular porosity within long bones of children with osteogenesis imperfecta.

Authors:  Carolyne Albert; John Jameson; Peter Smith; Gerald Harris
Journal:  Bone       Date:  2014-06-11       Impact factor: 4.398

2.  Bilateral atypical femur fractures without bisphosphonate exposure.

Authors:  Lauren K Szolomayer; Izuchukwu K Ibe; Dieter M Lindskog
Journal:  Skeletal Radiol       Date:  2016-11-30       Impact factor: 2.199

3.  Protocatechualdehyde Inhibits the Osteoclast Differentiation of RAW264.7 and BMM Cells by Regulating NF-κB and MAPK Activity.

Authors:  Yunyun Qu; Xin Liu; Shuai Zong; Huanxin Sun; Shuang Liu; Yueran Zhao
Journal:  Biomed Res Int       Date:  2021-07-16       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.